Literature DB >> 12929130

Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells.

Emi Tsukamoto1, Yuichi Hashimoto, Kohsuke Kanekura, Takako Niikura, Sadakazu Aiso, Ikuo Nishimoto.   

Abstract

Neuronal pathology of the brain with Alzheimer's disease (AD) is characterized by numerous depositions of amyloid-beta peptides (Abeta). Abeta binding to the 75-kDa neurotrophin receptor (p75NTR) causes neuronal cell death. Here we report that Abeta causes cell death in neuronal hybrid cells transfected with p75NTR, but not in nontransfected cells, and that p75NTR(L401K) cannot mediate Abeta neurotoxicity. We analyzed the cytotoxic pathway by transfecting pertussis toxin (PTX)-resistant G protein alpha subunits in the presence of PTX and identified that Galpha(o), but not Galpha(i), proteins are involved in p75NTR-mediated Abeta neurotoxicity. Further investigation suggested that Abeta neurotoxicity via p75NTR involved JNK, NADPH oxidase, and caspases-9/3 and was inhibited by activity-dependent neurotrophic factor, insulin-like growth factor-I, basic fibroblast growth factor, and Humanin, as observed in primary neuron cultures. Understanding the Abeta neurotoxic mechanism would contribute significantly to the development of anti-AD therapies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12929130     DOI: 10.1002/jnr.10703

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  27 in total

1.  Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis.

Authors:  Petar Podlesniy; Anton Kichev; Carlos Pedraza; Jordi Saurat; Mario Encinas; Begoña Perez; Isidre Ferrer; Carme Espinet
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 2.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

3.  p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation.

Authors:  Mina Yaar; Bennet L Arble; Kenneth B Stewart; Nazer H Qureshi; Neil W Kowall; Barbara A Gilchrest
Journal:  Cell Mol Neurobiol       Date:  2008-09-19       Impact factor: 5.046

4.  Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75.

Authors:  K Susen; A Blöchl
Journal:  J Mol Med (Berl)       Date:  2005-07-07       Impact factor: 4.599

Review 5.  Humanin: after the discovery.

Authors:  Takako Niikura; Tomohiro Chiba; Sadakazu Aiso; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

6.  Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR.

Authors:  Carlos E Pedraza; Petar Podlesniy; Noemí Vidal; Juan Carlos Arévalo; Ramee Lee; Barbara Hempstead; Isidre Ferrer; Montse Iglesias; Carme Espinet
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 7.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

8.  Alzheimer's disease is type 3 diabetes-evidence reviewed.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Diabetes Sci Technol       Date:  2008-11

9.  Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130.

Authors:  Yuichi Hashimoto; Megumi Kurita; Sadakazu Aiso; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Mol Biol Cell       Date:  2009-04-22       Impact factor: 4.138

10.  Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease.

Authors:  Catia Bellucci; Cinzia Lilli; Tiziano Baroni; Lucilla Parnetti; Sandro Sorbi; Carla Emiliani; Eleonora Lumare; Paolo Calabresi; Stefania Balloni; Maria Bodo
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.